TACTILE SYSTEMS TECHNOLOGY INC

# Tactile Systems Technology, Inc.

Based in Minneapolis, Minnesota, Tactile Systems Technology develops and commercializes medical devices for the treatment of chronic conditions characterized by fluid accumulation and compromised pulmonary function. The company's primary product portfolio consists of pneumatic compression devices designed for home-based patient care, addressing lymphedema, edema, venous insufficiency, and related conditions. The Flexitouch Plus system represents the company's flagship compression platform, while the Entre Plus System offers an alternative configuration for at-home lymphedema and chronic edema treatment. The company also markets Nimbl, a pneumatic compression platform targeting upper extremity lymphedema, and AffloVest, a wearable high-frequency chest wall oscillation device for patients with conditions including cystic fibrosis and bronchiectasis that result in retained pulmonary secretions.

Tactile Systems Technology supplements its device portfolio with digital health offerings, including Kylee, a mobile application that enables patients to track lymphedema symptoms, manage treatment protocols, and communicate clinical information with healthcare providers. The company operates with approximately 1,086 full-time employees and maintains a market capitalization of approximately $700 million. The company was incorporated in Minnesota in 1995 and maintains its headquarters in Minneapolis. Its products are distributed primarily throughout the United States market.